Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Suppression of HIV Infection”

155 trials

Showing 20 of 155 results

Early research (Phase 1)Study completedNCT01712425
What this trial is testing

Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals

Who this might be right for
HIV
IrsiCaixa 48
Large-scale testing (Phase 3)Study completedNCT05896748
What this trial is testing

Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1)
ViiV Healthcare 94
Not applicableStudy completedNCT03600103
What this trial is testing

Technology Based Community Health Nursing to Improve Combination Anti-Retroviral Therapy (cART) Adherence and Virologic Suppression in Youth Living With HIV

Who this might be right for
HIV InfectionsAdherence, Medication
Johns Hopkins University 76
Not applicableStudy completedNCT01898754
What this trial is testing

Oligonucleotide Ligation Assay (OLA) Resistance Study

Who this might be right for
HIV Positive
University of Washington 991
Early research (Phase 1)Study completedNCT00336778
What this trial is testing

Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression

Who this might be right for
HIV Infections
University of Maryland, Baltimore 6
Large-scale testing (Phase 3)Ended earlyNCT00562510
What this trial is testing

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

Who this might be right for
HIV Infections
Pedro Cahn 20
Not applicableStudy completedNCT02191202
What this trial is testing

Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression

Who this might be right for
HIV Infections
Boehringer Ingelheim 283
Not applicableStudy completedNCT00006441
What this trial is testing

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 398
Large-scale testing (Phase 3)Study completedNCT03403569
What this trial is testing

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

Who this might be right for
HIV-infection/AIDS
Peking Union Medical College Hospital 353
Not applicableLooking for participantsNCT06375135
What this trial is testing

Efficacy of mHealth + e-Navigator Stepped Care Intervention for ART Adherence Among Latino Men With HIV

Who this might be right for
ART Adherence
Florida International University 250
Not applicableStudy completedNCT00334022
What this trial is testing

Fuzeon Viral Decay Pilot Study

Who this might be right for
HIV-1
Canadian Immunodeficiency Research Collaborative 18
Post-approval studies (Phase 4)UnknownNCT01230580
What this trial is testing

Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)

Who this might be right for
HIV InfectionAcquired Immunodeficiency Syndrome
Medical Research Council 587
Large-scale testing (Phase 3)Study completedNCT00554398
What this trial is testing

Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 69
Post-approval studies (Phase 4)Study completedNCT01307488
What this trial is testing

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Who this might be right for
HIV Infection
Fundacion SEIMC-GESIDA 286
Not applicableLooking for participantsNCT05934305
What this trial is testing

Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

Who this might be right for
HivSubstance Use Disorders
Boston University 256
Post-approval studies (Phase 4)Study completedNCT00531557
What this trial is testing

Double Protease Inhibitor to Darunavir Switch Study

Who this might be right for
HIV Infections
St Stephens Aids Trust 12
Post-approval studies (Phase 4)Study completedNCT00966329
What this trial is testing

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Who this might be right for
HIVHIV Infections
Germans Trias i Pujol Hospital 30
Not applicableStudy completedNCT02772328
What this trial is testing

A Peer-based Mobile-health Intervention to Increase Access & Adherence to Hepatitis C Treatment & HIV Viral Suppression

Who this might be right for
Hepatitis CHIVRisk Reduction Behavior
Johns Hopkins Bloomberg School of Public Health 300
Not applicableStudy completedNCT03292432
What this trial is testing

Triggered Escalating Real-time Adherence (TERA) Intervention

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 89
Large-scale testing (Phase 3)Looking for participantsNCT06507059
What this trial is testing

Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals

Who this might be right for
HIV-1-infectionNon-Adherence, Medication
Chang Gung Memorial Hospital 40
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation